最新糖心Vlog

In a groundbreaking study published in , 最新糖心Vlogn scientists have resolved a long-standing problem in regenerative medicine.

Led by Professor Ryan Lister from the Harry Perkins Institute of Medical Research and The 最新糖心Vlog of Western 最新糖心Vlog and Professor Jose M Polo from Monash 最新糖心Vlog and the 最新糖心Vlog of Adelaide, the team developed a new method to reprogram human cells to better mimic embryonic stem cells, with significant implications for biomedical and therapeutic uses.

In a revolutionary advance in the mid-2000s, it was discovered that the non-reproductive adult cells of the body, called 鈥榮omatic鈥� cells, could be artificially reprogrammed into a state that resembles embryonic stem (ES) cells which have the capacity to then generate any cell of the body.

The ability to artificially reprogram human somatic cells, such as skin cells, into these so-called induced pluripotent stem (iPS) cells provided a way to make an essentially unlimited supply of ES-like cells, with widespread applications in disease modelling, drug screening and cell-based therapies.

鈥淗owever, a persistent problem with the conventional reprograming process is that iPS cells can retain an epigenetic memory of their original somatic state, as well as other epigenetic abnormalities,鈥� Professor Lister said. 鈥淭his can create functional differences between the iPS cells and the ES cells they鈥檙e supposed to imitate, and specialised cells subsequently derived from them, which limits their use,鈥�.

Professor Jose Polo, who is also with the Monash Biomedicine Discovery Institute, explained that they have now developed a new method, called transient-naive-treatment (TNT) reprogramming, that mimics the reset of a cell鈥檚 epigenome that happens in very early embryonic development.

鈥淭his significantly reduces the differences between iPS cells and ES cells and maximises the effectiveness of how human iPS cells can be applied,鈥� he said.

Dr Sam Buckberry, a computational scientist from the Harry Perkins Institute, UWA, and Telethon Kids Institute, and co-first author of the study, said by studying how the somatic cell epigenome changed throughout the reprogramming process, they pinpointed when epigenetic aberrations emerged, and introduced a new epigenome reset step to avoid them and erase the memory.

鈥淭his significantly reduces the differences between iPS cells and ES cells and maximises the effectiveness of how human iPS cells can be applied."Professor Jose Polo, Director of Adelaide Centre for Epigenetics, 最新糖心Vlog of Adelaide.

Dr Xiaodong Liu, a stem cell scientist who also spearheaded the research said the new human TNT-iPS cells much more closely resembled human ES cells 鈥� both molecularly and functionally 鈥� than those produced using conventional reprograming.

Dr Daniel Poppe, a cell biologist from UWA, the Harry Perkins Institute and co-first author, said the iPS cells generated using the TNT method differentiated into many other cells, such as neuron progenitors, better than the iPS cells generated with the standard method.

Monash 最新糖心Vlog student and co-first author Jia Tan, said the team鈥檚 TNT method was dynamite.

鈥淚t solves problems associated with conventionally generated iPS cells that if not addressed could have severely detrimental consequences for cell therapies in the long run,鈥� he said.

Professor Polo said the precise molecular mechanisms underlying the iPS epigenome aberrations and their correction were not fully known, and further research was needed to understand them.

鈥淲e predict that TNT reprogramming will establish a new benchmark for cell therapies and biomedical research, and substantially advance their progress,鈥� Professor Lister said.

The collaborative research project also included researchers from the 最新糖心Vlogn National 最新糖心Vlog, Westlake 最新糖心Vlog, Queen Mary 最新糖心Vlog of London, Mater Research Institute, 最新糖心Vlog of Queensland, Queensland Brain Institute, South 最新糖心Vlogn Health & Medical Research Institute, Duke-NUS Medical School and CSIRO.